Aroa Biosurgery Ltd (AU:ARX) has released an update.
Aroa Biosurgery Limited, a New Zealand-based soft tissue regeneration company, will hold a webinar on April 30, 2024, to discuss its March quarterly results with CEO Brian Ward and CFO James Agnew. The company has corrected a previous announcement that erroneously referred to the December quarter. Interested parties can register for the event and submit questions in advance or use the live Q&A function during the webinar.
For further insights into AU:ARX stock, check out TipRanks’ Stock Analysis page.
